Covered recipient · General Payments record
SAPAN BINDAL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,686.61
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $555.58 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $276.71 | 8 |
| Janssen Pharmaceuticals, Inc | $147.94 | 2 |
| Lilly USA, LLC | $76.73 | 5 |
| SANOFI PASTEUR INC. | $22.64 | 1 |
| DEXCOM, INC. | $18.38 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $13.18 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086251594 | CMS |
| Dexcom, Inc. | $18.38 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153334247 | CMS |
| Janssen Pharmaceuticals, Inc | $123.94 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078208229 | CMS |
| Janssen Pharmaceuticals, Inc | $24.00 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078208177 | CMS |
| Lilly USA, LLC | $16.07 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135389711 | CMS |
| Lilly USA, LLC | $17.10 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135375304 | CMS |
| Lilly USA, LLC | $13.29 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135389713 | CMS |
| Lilly USA, LLC | $14.07 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135365716 | CMS |
| Lilly USA, LLC | $16.20 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135343437 | CMS |
| Novo Nordisk Inc | $16.24 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096928508 | CMS |
| Novo Nordisk Inc | $17.33 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096663137 | CMS |
| Novo Nordisk Inc | $13.39 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096606509 | CMS |
| Novo Nordisk Inc | $95.51 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096790220 | CMS |
| Novo Nordisk Inc | $14.22 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096684116 | CMS |
| Novo Nordisk Inc | $15.25 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096610698 | CMS |
| Novo Nordisk Inc | $17.38 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097078588 | CMS |
| Novo Nordisk Inc | $87.39 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097039824 | CMS |
| SANOFI PASTEUR INC. | $22.64 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128762568 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.